1988
DOI: 10.1097/00002093-198802020-00018
|View full text |Cite
|
Sign up to set email alerts
|

Adverse drug reactions associated with global cognitive impairment in elderly persons

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
90
0
2

Year Published

1994
1994
2011
2011

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 68 publications
(95 citation statements)
references
References 0 publications
3
90
0
2
Order By: Relevance
“…Multiple medication use is associated with greater use of inappropriate medications and non-adherence, and imposes substantial cost burdens on older patients even when they have prescription drug insurance 3-5. In addition, the frequency of adverse drug events rises in proportion to the number of medications used, including drug-specific phenomena as well as non-specific syndromes including weight loss, falls, and decline in functional and cognitive status 6-10. Such adverse drug events affect an estimated 5-35% of older patients living in the community per year, and are responsible for approximately 10% of hospital admissions in older adults 11-15…”
Section: Perspectivesmentioning
confidence: 99%
“…Multiple medication use is associated with greater use of inappropriate medications and non-adherence, and imposes substantial cost burdens on older patients even when they have prescription drug insurance 3-5. In addition, the frequency of adverse drug events rises in proportion to the number of medications used, including drug-specific phenomena as well as non-specific syndromes including weight loss, falls, and decline in functional and cognitive status 6-10. Such adverse drug events affect an estimated 5-35% of older patients living in the community per year, and are responsible for approximately 10% of hospital admissions in older adults 11-15…”
Section: Perspectivesmentioning
confidence: 99%
“…In a review of the evidence, Verdoux et al 11 commented on the ‘discrepant findings’ on the risk of cognitive decline and concluded that ‘the hypothesis that long-term exposure to benzodiazepines may induce permanent brain damage is merely speculative’. A third strain of evidence comes from pharmacological studies that have identified acute adverse cognitive effects of benzodiazepine use in older persons,1 12 which may persist for over 6 months after withdrawal of medication 13. Further evidence is therefore required to establish whether benzodiazepine use has any long-term adverse cognitive implications.…”
Section: Introductionmentioning
confidence: 99%
“…CNS-active medications (e.g., benzodiazepines, opioids, tricyclic antidepressants, traditional antipsychotics) are commonly prescribed to older adults and represent a frequent cause of adverse medication effects, including problems with mobility, falls, and cognition in older patients 13. Medications that adversely affect cognition in particular lead to increased morbidity and health care utilization among older people 13.…”
Section: Introductionmentioning
confidence: 99%
“…Medications that adversely affect cognition in particular lead to increased morbidity and health care utilization among older people 13. More importantly, CNS-medication-induced cognition problems may be reversed by adjusting or discontinuing these medications altogether 2, 46…”
Section: Introductionmentioning
confidence: 99%